Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Telik and Cor Therapeutics enter drug screening and licensing agreement

Jan. 14, 1999

Medarex receives milestone payment from Centocor related to HuMAb-Mouse technology

Jan. 13, 1999

Key proteomics patents issued to Oxford GlycoSciences

Jan. 13, 1999

Isolex 300 and 300i cell selection system is approvable, FDA says

Jan. 12, 1999

Incyte announces new database agreement with P&U

Jan. 11, 1999

Genelabs and DuPont renew collaboration on novel compounds that regulate gene expression

Jan. 8, 1999

New family of gene-regulating enzymes discovered by Signal, Hebrew University

Jan. 7, 1999

U.S. patent issued to Millennium covers novel forms of caspase 8

Jan. 7, 1999

Sugen awarded U.S. patent for transcript imaging technology

Jan. 7, 1999

Telomerase expression extends lifespan of normal human cells without oncogenic transformation

Jan. 4, 1999

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...